Fondazione Schena Report issue

Foundation

Organization Overview

First Clinical Trial
2017
NCT03408847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fondazione Schena

Active Ingredients

Drugs in Other Trials (2)

beclomethasone (vanceril) (1 trial)

olive (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2